HARVARD BIOSCIENCE, INC. Estimated Litigation Liability, Current
HARVARD BIOSCIENCE, INC. (HBIO) had Estimated Litigation Liability, Current of $472.00 thousand as of 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LitigationReserveCurrent · last filed 2022-08-04
- 2022-06-30: Estimated Litigation Liability, Current $472.00K.
- 2022-03-31: Estimated Litigation Liability, Current $4.81M.
- 2021-12-31: Estimated Litigation Liability, Current $0.00.
| Period end | Estimated Litigation Liability, Current |
|---|---|
| 2022-06-30 | $472.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $4.81M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $0.00 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |